The preparation and SAR of several piperazic acid-based stromelysin (MMP-3) inhibitors is presented. The standard P3' methyl amide substituent can be replaced by other carboxy based substituents and maintain good binding affinity. Removal of a hydrogen-bond acceptor results in a 30-fold decrease in activity.